Rigel Pharmaceuticals, Inc. v. Servier Pharmaceuticals LLC et al. > Summary
Court Case Number IPR2022-01423
Filing Date Aug 15, 2022
Institution Decision Date -
Decision Date Jan 6, 2023
Court Patent Trial and Appeal Board
Status Terminated-Settled
Administrative JudgesGrace Karaffa Obermann, Donna M. Praiss, Christopher L. Crumbley
Judge Writing the Final DecisionGrace Karaffa Obermann
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 9, 10, 11, 12
Petitioner
Petitioner Attorneys
5Rigel Pharmaceuticals
Attorney Name: James L. Lovsin
McDonnell Boehnen Hulbert & Berghoff LLP
Rigel Pharmaceuticals
Attorney Name: James V. Suggs
McDonnell Boehnen Hulbert & Berghoff LLP
Rigel Pharmaceuticals
Attorney Name: David H. Sherman
McDonnell Boehnen Hulbert & Berghoff LLP
Rigel Pharmaceuticals
Attorney Name: Leslie Oleksowicz
McDonnell Boehnen Hulbert & Berghoff LLP
Patent Owner Attorneys
8Dang, LLC
Attorney Name: William M Fink
O’Melveny & Myers LLP
Dang, LLC
Attorney Name: Benjamin M. Haber
O’Melveny & Myers LLP
Dang, LLC
Attorney Name: James Yuanxin Li
O’Melveny & Myers LLP
Dang, LLC
Attorney Name: Joseph Don Eng
King & Spalding
Dang, LLC
Attorney Name: Vanessa Y. Yen
King & Spalding
Dang, LLC
Attorney Name: Evan D. Diamond
King & Spalding
Dang, LLC
Attorney Name: Jonathan Weinberg
King & Spalding
Servier Pharmaceuticals LLC
Attorney Name: Hassen A. Sayeed
O'Melveny & Myers LLP
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10610125 | Methods and compositions for cell-proliferation-related disorders | Apr 7, 2020 |
